109 related articles for article (PubMed ID: 28532694)
21. Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection.
Yamada R; Hiramatsu N; Oze T; Morishita N; Harada N; Yakushijin T; Iio S; Doi Y; Yamada A; Kaneko A; Hagiwara H; Mita E; Oshita M; Itoh T; Fukui H; Hijioka T; Katayama K; Tamura S; Yoshihara H; Imai Y; Kato M; Miyagi T; Yoshida Y; Tatsumi T; Kasahara A; Hamasaki T; Hayashi N; Takehara T;
J Gastroenterol; 2015 Jul; 50(7):785-94. PubMed ID: 25384794
[TBL] [Abstract][Full Text] [Related]
22. Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B - authors' reply.
Fu SC; Huang YW
Aliment Pharmacol Ther; 2015 Jul; 42(1):118-9. PubMed ID: 26040519
[No Abstract] [Full Text] [Related]
23. Adequate interval for hepatocellular carcinoma surveillance.
Giannini EG; Farinati F; Trevisani F
Am J Gastroenterol; 2013 Jul; 108(7):1174. PubMed ID: 23820997
[No Abstract] [Full Text] [Related]
24. Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.
Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Arakawa T; Fujimori M
J Med Virol; 2010 Apr; 82(4):539-45. PubMed ID: 20166172
[TBL] [Abstract][Full Text] [Related]
25. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Basyigit S; Sapmaz F
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1230. PubMed ID: 26327502
[No Abstract] [Full Text] [Related]
26. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
[TBL] [Abstract][Full Text] [Related]
27. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
[TBL] [Abstract][Full Text] [Related]
28. Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.
Acalovschi M
Rom J Gastroenterol; 2003 Jun; 12(2):123-30. PubMed ID: 12853999
[No Abstract] [Full Text] [Related]
29. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
[TBL] [Abstract][Full Text] [Related]
30. Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.
Young K; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
J Viral Hepat; 2017 Sep; 24(9):789-796. PubMed ID: 28273387
[TBL] [Abstract][Full Text] [Related]
31. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
32. Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy.
Shim JJ; Oh CH; Kim JW; Lee CK; Kim BH
Scand J Gastroenterol; 2017 Sep; 52(9):1029-1036. PubMed ID: 28562104
[TBL] [Abstract][Full Text] [Related]
33. Risk assessment for hepatocellular carcinoma in chronic hepatitis B: scores and surveillance.
Gonzalez SA; Keeffe EB
Int J Clin Pract; 2012 Jan; 66(1):7-10. PubMed ID: 22171899
[TBL] [Abstract][Full Text] [Related]
34. Response to Giannini et al.
Wang JH; Lu SN
Am J Gastroenterol; 2013 Jul; 108(7):1175. PubMed ID: 23820998
[No Abstract] [Full Text] [Related]
35. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
[TBL] [Abstract][Full Text] [Related]
36. HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles.
Tseng TC; Kao JH
Gastroenterology; 2008 Apr; 134(4):1272-3; author reply 1273. PubMed ID: 18395116
[No Abstract] [Full Text] [Related]
37. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
Ji J; Sundquist K; Sundquist J
J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
[TBL] [Abstract][Full Text] [Related]
38. Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis B virus infection in Sweden.
Sundquist K; Sundquist J; Ji J
J Med Virol; 2014 Jan; 86(1):18-22. PubMed ID: 24038002
[TBL] [Abstract][Full Text] [Related]
39. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.
Walter SR; Thein HH; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Gastroenterol Hepatol; 2011 Dec; 26(12):1757-64. PubMed ID: 21615789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
